NovoTTF-200A

Details

Files
Generic Name:
NovoTTF-200A
Project Status:
Active
Therapeutic Area:
Supratentorial glioblastoma (GBM)
Manufacturer:
Novocure Canada Inc.
Call for patient/clinician input open:
Brand Name:
Optune
Project Line:
Health Technology Review
Project Sub Line:
Optimal Use
Project Number:
OP0554-000
Call for patient/clinician input closed:

To enhance the quality and relevance of this work, CADTH is engaging people with extensive personal and/or professional experience within the Canadian health system.

Key Milestones2
Call for patient/clinician input openJuly 13, 2023
Call for patient/clinician input closedSeptember 1, 2023
Submission receivedAugust 18, 2023
Submission acceptedSeptember 1, 2023
Review initiatedSeptember 5, 2023
Draft recommendation posted for stakeholder feedbackFebruary 1, 2024
End of feedback periodFebruary 15, 2023